Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC). [electronic resource]
Producer: 20080821Description: 1417-1422 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- drug therapy
- Camptothecin -- administration & dosage
- DNA Topoisomerases, Type I -- biosynthesis
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Synergism
- Female
- Gene Expression
- Humans
- Irinotecan
- Leukocytes, Mononuclear -- enzymology
- Middle Aged
- Mitomycin -- administration & dosage
- NAD(P)H Dehydrogenase (Quinone) -- biosynthesis
- Neoplasm Metastasis
- Polymorphism, Single Nucleotide
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.